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Detectionofnucleicacidsand inductionof type I inter-
ferons (IFNs) are principal elements of antiviral de-
fense but can cause autoimmunity if misregulated.
Cytosolic DNA detection activates a potent, cell-
intrinsic antiviral response through a poorly defined
pathway. In a screen for proteins relevant to this
IFN-stimulatory DNA (ISD) response, we identify 30 re-
pair exonuclease 1 (Trex1). Mutations in the human
trex1 gene cause Aicardi-Goutieres syndrome (AGS)
and chilblain lupus, but the molecular basis of these
diseases is unknown.We define Trex1 as an essential
negative regulator of the ISD response and delineate
the genetic pathway linking Trex1 deficiency to lethal
autoimmunity. We show that single-stranded DNA
derived fromendogenous retroelementsaccumulates
in Trex1-deficient cells, and that Trex1 canmetabolize
reverse-transcribed DNA. These findings reveal a
cell-intrinsic mechanism for initiation of autoimmu-
nity, implicate the ISD pathway as the cause of AGS,
and suggest an unanticipated contribution of endo-
genous retroelements to autoimmunity.
INTRODUCTION
Detection of foreign nucleic acids is an ancient form of host de-
fense. In vertebrates, nucleic acid detection activates a program
of antiviral defense designed to neutralize the spread of infec-
tion. This antiviral program is coordinated by type I interferons
(IFNs), which direct a multifaceted response to restrict viral
replication within infected cells, alert neighboring cells to the
presence of infection, and expand effector lymphocytes to pro-
vide long-term and specific protection against the virus (Stark
et al., 1998; Stetson and Medzhitov, 2006b).
Two complementary systems link nucleic acid detection to the
IFN-mediated antiviral response. One system consists of several
Toll-like receptors (TLRs), which are transmembrane sensors ex-
pressed on sentinel immune cells that sample endosomal cargo
for nucleic acids (Takeda et al., 2003). As such, TLRs comprisea non-cell-autonomous mechanism whereby uninfected im-
mune cells sense viral infection by detecting free viral particles
or viral nucleic acids within phagocytosed apoptotic cells (Pichl-
mair and Reis e Sousa, 2007). A second, more broadly ex-
pressed system detects viral nucleic acids within the infected
cell itself. This system is exemplified by the cytosolic RNA heli-
cases RIG-I and MDA5, which signal activation of a cell-intrinsic
antiviral response through the adaptor protein IPS-1 (also known
as MAVS, CARDIF, or VISA; reviewed by Pichlmair and Reis
e Sousa (2007). Recently, a cytosolic antiviral pathway that
detects DNA was described (Ishii et al., 2006; Martin and Elkon,
2006; Okabe et al., 2005; Stetson and Medzhitov, 2006a). This
system, termed the IFN-stimulatory DNA (ISD) response, is anal-
ogous to the RIG-I and MDA5 RNA helicases in that it is cell
intrinsic. However, the ISD pathway engages a distinct signaling
cascade that is IPS-1-independent (Kumar et al., 2006; Sun
et al., 2006), possibly through activation of the candidate ISD
sensor DAI (Takaoka et al., 2007). Although little is known about
the upstream signaling events that distinguish the ISD response
from RIG-I- and MDA5-mediated RNA recognition, both path-
ways activate potent type I IFN production through the transcrip-
tion factor IFN regulatory factor 3 (IRF3) (Ishii et al., 2006; Stetson
and Medzhitov, 2006a).
Together, these two types of nucleic acid detection systems—
TLRs and cytosolic sensors—account for essentially all IFN-me-
diated antiviral immunity (Koyama et al., 2007). However, discrim-
ination of viral from self-nucleic acids is imperfect, and recent
studies have shown that defective clearance of self-derived
nucleic acids can cause severe, IFN-associated autoimmunity.
For example, deficiency for the extracellular DNase I causes a lu-
pus-like syndrome in mice (Napirei et al., 2000), and DNase I mu-
tations in humans are associated with lupus (Yasutomo et al.,
2001). One major mechanism by which these extracellular nucleic
acids cause autoimmunity is through activation of TLRs on auto-
reactive B cells (Leadbetter et al., 2002). TLR7 and TLR9 are im-
portant for autoantibody production in a murine model of lupus
(Christensen et al., 2006), and a spontaneous gene duplication
of murine TLR7 predisposes to autoimmunity (Pisitkun et al.,
2006; Subramanian et al., 2006). A complex of extracellular
DNA and the antimicrobial peptide LL37 activates TLR9-depen-
dent IFN production by plasmacytoid dendritic cells (pDCs) in
human psoriasis (Lande et al., 2007). Notably, liver macrophagesCell 134, 587–598, August 22, 2008 ª2008 Elsevier Inc. 587
in mice lacking the lysosomal DNase II become engorged with the
ejected nuclei of erythrocyte precursors and develop a TLR-inde-
pendent IFN response to this undigested DNA (Okabe et al., 2005;
Yoshida et al., 2005).
Importantly, all of these examples involve non-cell-autono-
mous mechanisms in that the source of the accumulated nucleic
acids is distinct from the cells that detect them. In contrast, it is
unclear whether accumulation of self-nucleic acids within cells
can activate cytosolic sensors, because a situation where this
occurs has not yet been identified. Given the importance of these
cell-intrinsic nucleic acid sensors in antiviral defense, a number
of fundamental questions regarding the principles of self-/non-
self discrimination arise. Specifically, are there dedicated mech-
anisms that limit excessive activation of cytosolic nucleic acid
sensors? What happens when these mechanisms break
down? In addition, can cell-intrinsic nucleic acid detection cause
autoimmunity if improperly controlled?
Here, we developed an approach to isolate proteins relevant
to the ISD response and identified 30 repair exonuclease 1
(Trex1) as an ISD binding protein. Trex1 is the most abundant
30/50 DNA exonuclease in cells (Hoss et al., 1999; Lindahl
et al., 1969; Mazur and Perrino, 1999). Loss of function mutations
in the human Trex1 gene cause Aicardi-Goutieres syndrome
(AGS; Crow et al., 2006a). AGS presents in infancy as a severe
encephalitis with intracranial calcifications, lymphocyte infil-
trates, and elevated type I IFN levels in cerebrospinal fluid, and
demyelination of motor neurons with accompanying psychomo-
tor retardation (Rice et al., 2007b). Many of these symptoms
resemble those caused by congenitally acquired infection with
cytomegalovirus or rubella virus (Crow et al., 2003; Sanchis
et al., 2005), but no viral pathogen has been detected in AGS pa-
tients. Different Trex1 mutations also cause monogenic chilblain
lupus, and are found more frequently in people with systemic
lupus erythematosus than in healthy individuals, suggesting
that a common mechanism may underlie these disorders (Alar-
con-Riquelme, 2006; Lee-Kirsch et al., 2007a, 2007b; Rice
et al., 2007a). Trex1-deficient mice exhibit dramatically reduced
postnatal survival; the principal cause of mortality in these mice
is circulatory failure caused by inflammatory myocarditis (Morita
et al., 2004).
Despite the emerging evidence linking Trex1 deficiency to au-
toimmunity, little is known about the specific mechanisms that
lead to disease in the absence of Trex1. Herein, we define
Trex1 as a negative regulator of the ISD response and delineate
the genetic pathway linking cell-intrinsic initiation of autoimmu-
nity to type I IFN-dependent autoantibody production and auto-
immune pathology. We identify single-stranded DNA (ssDNA)
fragments derived from endogenous retroelements that accu-
mulate in Trex1-deficient hearts, and show that Trex1 can
metabolize reverse-transcribed DNA of these endogenous retro-
elements, revealing a source of Trex1 substrates that may trigger
autoimmunity.
RESULTS
Identification of Trex1 as an ISD Binding Protein
We designed an unbiased biochemical approach to identify pro-
teins involved in ISD recognition based on direct binding to cyto-588 Cell 134, 587–598, August 22, 2008 ª2008 Elsevier Inc.solic DNA in live cells. We took advantage of the fact that the ISD
response is sequence independent, and synthesized biotiny-
lated oligonucleotides with several bromodeoxyuridine (BrdU)
nucleosides in place of thymidine; BrdU more readily crosslinks
to closely associated proteins upon exposure to ultraviolet (UV)
light. We transfected the BrdU-modified ISD into macrophages,
UV treated the cells 90 min later, and recovered the biotinylated
DNA/protein complexes from cell lysates. Mass spectrometry
analysis identified a prominent recovered protein as Trex1 (Fig-
ure 1A), which we confirmed by western blot with antisera to
Trex1 (Figure 1B).
Analysis of microarray data revealed that, in addition to its
steady-state abundance, transcription of the trex1 gene is ro-
bustly induced by ISD stimulation (Figure 1C). Of all 30/50
DNA exonucleases in the mouse genome, Trex1 is uniquely
ISD inducible, which suggests a more specialized role for
Trex1 in antiviral immunity (Figure 1C). We found that Trex1-
deficient cells had an intact ISD response to transfected DNA,
thus ruling out the possibility that Trex1 is the ISD sensor itself
(Figure 1D).
Consistent with a previous report (Chowdhury et al., 2006), we
found that Trex1 was cytosolic and localized to the endoplasmic
reticulum (ER; Chowdhury et al., 2006). The C-terminal region of
Trex1 that follows the nuclease domain was necessary for this
ER localization: a truncated form of Trex1 lacking the last 79
amino acids was located diffusely throughout the cell (Figure 1E).
Notably, a missense mutation in human Trex1 resulting in a sim-
ilarly truncated protein causes autosomal dominant retinal
vasculopathy with cerebral leukodystrophy (OMIM 192315),
underscoring the importance of this ER localization (Richards
et al., 2007). Fusion of the C-terminal 79 amino acids of Trex1
to the C terminus of yellow fluorescent protein (YFP) conferred
ER localization identical to that of full-length Trex1 (Figure 1E)
(Richards et al., 2007).
Trex1 contains a predicted transmembrane helix at its C termi-
nus, suggesting that it may be an integral membrane protein of
the ER (Lee-Kirsch et al., 2007b). However, Trex1 lacks an iden-
tifiable signal sequence for ER insertion, either at its N terminus
or within the 79 C-terminal amino acids that dictate ER localiza-
tion. When we examined the migration of epitope-tagged Trex1
in sucrose gradients, we unexpectedly found two distinct pools
of Trex1: a buoyant fraction that migrated at the top of the gradi-
ent, and a dense fraction that coeluted with calnexin, an ER-
resident, transmembrane protein (Figure 1F). Removal of the
Trex1 C terminus eliminated the dense pool, while fusion of
this C terminus to YFP resulted in a dual distribution identical
to that of full-length Trex1 (Figure 1F). The dense form of Trex1
was also eliminated by pretreatment of cell extracts with deter-
gent (0.5% NP-40; data not shown). These data suggest that
Trex1 is not a transmembrane protein, and that a fraction of
Trex1 interacts through its C terminus with ER membranes or
with another ER-resident protein to determine its localization.
Trex1 Is a Negative Regulator of the ISD Pathway
Trex1 is an ISD-inducible DNA exonuclease, but it is not the sen-
sor of the ISD pathway. We therefore hypothesized that Trex1
may play a regulatory role in the ISD pathway by metabolizing
DNA ligands of this cell-intrinsic antiviral response. Because
Figure 1. Biochemical Identification of Trex1 as an ISD Binding Protein
(A) Proteins specifically recovered with BrdU-substituted, biotinylated ISD were visualized by silver staining. Arrows indicate the bands identified as Trex1.
(B) Cells transfected with BrdU-substituted, biotinylated ISD were exposed to UV light at the indicated times post transfection. Trex1 association with recovered
ISD was visualized by western blot. WCE = whole cell extract.
(C) We examined microarray data (Stetson and Medzhitov, 2006a) of macrophages treated for 4 hr with ISD and plotted the fold change in expression in log2
format versus the sum of untreated and treated expression values for all 30/50 DNA exonucleases in the mouse genome (Shevelev and Hubscher, 2002).
Trex1 is indicated in red.
(D) Bone marrow-derived macrophages of the indicated Trex1 genotype were transfected with ISD. IFNb and IL-6 mRNA expression 4 hr posttransfection were
measured by quantitative RT-PCR, normalized to HPRT expression within each sample, and compared to untreated controls to calculate the relative expression.
(E) HeLa cells were transfected with vectors encoding tagged, full-length Trex1 (left panel), Trexl lacking the C-terminal 76 amino acids (middle panel), or YFP
fused to the C-terminal 76 amino acids of Trex1 (right panel), and visualized by immunofluorescence microscopy. Magnification, 4003.
(F) The 293T cells were transfected with expression vectors for haemagluttinin (HA)-tagged Trexl, HA-Trex1 (1–235), eYFP, or eYFP fused to Trex1 (236–315).
Extracts from mechanically disrupted cells were centrifuged through a 10%–60% sucrose gradient, and the position of each protein in harvested fractions
was determined by western blot for HA (top two panels), eYFP (third and fourth panels), or calnexin (bottom panel).IRF3 is essential for the antiviral ISD response (Stetson and
Medzhitov, 2006a), we examined the contribution of the ISD-
IRF3 pathway by breeding Trex1-deficient mice to IRF3-deficient
mice (Sato et al., 2000). Importantly, IRF3 dependence distin-
guishes the ISD pathway from TLR9-dependent recognition of
DNA, which activates type I IFNs in pDCs through the related
IRF7 transcription factor (Honda et al., 2005; Kawai et al.,
2004). Trex1-deficient mice in our colony succumbed to lethal
autoimmunity at a median age of 9 weeks (Figure 2A). In contrast,
genetic ablation of IRF3 prevented disease in Trex1-deficient
mice, as evidenced by complete rescue from mortality and
restoration of normal body weight (Figures 2A and 2B).
We performed two additional crosses to further dissect the
phenotype of Trex1-deficient mice. Detection of intracellular
DNA by the ISD pathway activates potent type I IFN production,
and elevated type I IFNs are a hallmark of AGS and lupus (Crow
et al., 2003; Pascual et al., 2006; Theofilopoulos et al., 2005).
Similar to Trex1/IRF3 double knockout (DKO) mice, Trex1-defi-
cient mice lacking the type I IFN receptor (IFNaR1) were com-
pletely protected from mortality (Figure 2C). Finally, we found
that lymphocytes were essential for disease, because RAG2deficiency fully rescued Trex1-deficient mice from mortality
(Figure 2D).
Most Trex1-deficient mice die of circulatory failure caused by
severe inflammatory myocarditis (Morita et al., 2004). All hearts
examined from Trex1-deficient mice in our colony had evidence
of profound inflammation, with thinning of the ventricular wall,
mononuclear cell infiltrates, and disruption of normal heart mus-
cle morphology (Figure 3A). These pathological features were
absent in Trex1-deficient mice lacking IRF3, IFNaR1, or RAG2
(Figure 3A). Interestingly, despite the restoration of normal heart
anatomy in Trex1-deficient mice on all three rescued back-
grounds, we found distinct effects of each rescuing genotype
on type I IFN expression in heart tissue. IFN-b mRNA expression
was dramatically increased in Trex1-deficient hearts and com-
pletely restored to wild-type levels in Trex1/IRF3 DKO hearts,
further emphasizing the primary role of IRF3 in this IFN-depen-
dent pathology (Figure 3B). Trex1/IFNaR1 DKO hearts had low
but detectably elevated levels of IFN-b mRNA, consistent with
disruption of the positive feedback loop of type I IFN expression
that is amplified by IFNaR1 signaling (Figure 3B). In contrast,
hearts of Trex1/RAG2 DKO mice retained significantly elevatedCell 134, 587–598, August 22, 2008 ª2008 Elsevier Inc. 589
Figure 2. Genetic Dissection of the Trex1 Knockout Phenotype
(A) Survival curves for Trex1-deficient mice of the indicated irf3 genotype. Trex1/ irf3+/+ mice include mice generated both by intercrossing trex1+/ irf3+/ mice
as well as by separately intercrossing trex1+/ irf3+/+ mice. These latter mice are also included as ‘‘WT’’ for the crosses in Figures 2C and 2D. The number of mice
of each genotype is indicated in parentheses, and symbols represent individual mice.
(B) Body weights of mice of the indicated genotype were measured at 4.5 weeks of age and compared to the average weight of sex-matched, WT littermates. For
these measurements, trex1+/ mice were considered WT.
(C) Survival curves for Trex1-deficient mice of the indicated ifnar1 genotype.
(D) Survival curves for Trex1-deficient mice of the indicated rag2 genotype.levels of IFN-b mRNA (Figure 3B). Importantly, these data indi-
cate that expression of type I IFNs alone is not sufficient to cause
disease; rather, it is the IFN-dependent mobilization of lympho-
cytes that precipitates autoimmunity in this setting.590 Cell 134, 587–598, August 22, 2008 ª2008 Elsevier Inc.The Trex1/RAG2 DKO mice revealed an unexplored stage of
disease after initiation and before lymphocyte-dependent
pathology. To further characterize this postinitiation phase, we
performed a microarray analysis comparing heart tissue ofFigure 3. Amelioration of Autoimmunity through Intervention at Three Phases of Disease
(A) Paraffin-embedded heart tissue sections from mice of the indicated age and genotype were stained with H&E. The top panels are at 1003 and the bottom
panels are at 2003 magnification.
(B) IFNb mRNA levels in hearts of mice of the indicated genotype were determined by quantitative RT-PCR, normalized to HPRT expression within each sample,
and compared to WT littermates to calculate the relative IFNb expression.
(C) Gene expression analysis of heart tissue from three pairs of Trex1/RAG2 DKO and RAG2 KO littermates, aged 18, 19, and 28 weeks. Data are presented in log2
format and represent means ± SD of differential expression in Trex1-deficient hearts compared to wild-type (WT) hearts.
Figure 4. The ISD Pathway Is Essential for Autoantibodies in Trex1-Deficient Mice
(A) IgG autoantibodies were detected by incubating Trex1/RAG2 DKO heart tissue sections with sera of the indicated genotype and then with fluorescently
labeled secondary antibodies to mouse IgG. IgG signal is colored green, and DAPI staining of nuclei is in blue. The images in the left and middle panels are
at 2003 magnification; right panels are 16003 digital zooms of the fields demarcated by the white boxes.
(B) IgG autoantibodies were detected by western blot against heart protein extracts, prepared from Trex1/RAG2 DKO (KO) or RAG2 KO (WT) mice and used neat
or diluted 1:5.
(C) Heart extracts were prepared as described for Figure 1B and incubated with sera harvested from individual mice of the indicated age and genotype. For each
western blot, the left lane is KO extract and the right lane is WT extract.Trex1/RAG2 DKO hearts to RAG2 KO littermate controls. We
found that ISD- and IFN-inducible genes comprised over 75%
of the top 50 genes with increased expression levels in Trex1-
deficient hearts, further emphasizing the role of the ISD pathway
in initiating disease (Figure 3C) (Stetson and Medzhitov, 2006a).
Taken together, these findings indicate that Trex1 substrates
are ligands of the ISD pathway. Accumulation of these sub-
strates within Trex1-deficient cells initiates IRF3-dependent
type I IFN production, which, in turn, recruits and activates lym-
phocytes to attack the affected tissues. Genetic ablation of IRF3,
IFNaR1, or RAG2 ameliorates disease at three discrete phases,
thus defining a genetic pathway connecting unregulated cell-in-
trinsic DNA detection by the ISD pathway to lethal autoimmunity.
The ISD Pathway Is Required for Autoantibody
Production in Trex1-Deficient Mice
Because lymphocytes are essential for the autoimmune pathol-
ogy caused by loss of Trex1 function, we tested for the presence
of autoantibodies in Trex1-deficient mice. Sera from wild-type
mice showed no detectable reactivity with heart tissue sections
(Figure 4A, left panels). In contrast, IgG antibodies from Trex1-de-
ficient mice strongly stained heart tissue (Figure 4A, middle and
right panels). Sera from different Trex1 KO mice reproducibly
detected similar cytosolic structures (Figure 4A). This cytosolic
staining pattern was different from the nuclear and punctate cy-
tosolic distribution of autoantigens detected by autoantibodies
from MRL-lpr/lpr mice that develop systemic autoimmunity
(Figure 4A, bottom row). Autoantibodies from Trex1-deficient
mice detected KO and wild-type heart extracts equivalently,demonstrating that the autoantigens were not specific to Trex1
KO hearts (Figures 4B and 4C). Moreover, we observed a trend
toward broader autoreactivity with sera from older Trex1-
deficient mice, consistent with epitope spreading (Figures 4B
and 4C).
We next tested whether the ISD pathway was linked to autoan-
tibody production in Trex1-deficient mice. Sera from all singly
Trex1-deficient mice tested demonstrated strong reactivity to
heart extracts of both wild-type and Trex1 KO mice (Figure 4C).
In contrast, serum autoantibodies were undetectable in similarly
aged Trex1 KO mice lacking either IRF3 or IFNaR1 (Figure 4C).
These data reveal an important connection between the ISD
pathway and the generation of autoantibodies, and suggest
a probable explanation for the contribution of lymphocytes to
disease in Trex1-deficient mice.
Identification of Endogenous Trex1 DNA Substrates
The data presented above suggest that accumulation of Trex1
DNA substrates activates the ISD pathway, raising questions
about the nature and the source of this DNA. We developed
a method to purify, amplify, and directionally clone these endog-
enous Trex1 DNA substrates directly from hearts of Trex1-defi-
cient mice (Figure 5A). We homogenized hearts in the presence
of 200 mM digitonin to selectively disrupt cholesterol-rich plasma
membranes and minimize extraction of other organelles. Purified
DNA was tailed with dTTP by using terminal deoxynucleotidyl
transferase (TdT), and then copied with Klenow DNA polymerase
and a primer specific for the poly-dT DNA tail. This complemen-
tary DNA strand was then tailed with dCTP to yield ssDNA withCell 134, 587–598, August 22, 2008 ª2008 Elsevier Inc. 591
Figure 5. Identification of Endogenous Trex1 Substrates
(A) Schematic of the strategy used to tag and amplify DNA fragments purified from heart tissue.
(B) DNA was purified from pooled hearts of three irf3/ mice and three trex1/ irf3/ mice and PCR-amplified for the indicated number of cycles. The negative
control revealed the nonspecific (ns) amplicon, and the positive control amplified a tailed, 58 base DNA oligonucleotide.
(C) The percentage of unique clones and clones with an endogenous Poly-dT stretch immediately 30 of the insert are indicated, with the total number of clones per
genotype above each bar.
(D) The relative percentage of each type of DNA fragment within the pool of unique clones.
(E) Expression levels of 45,037 features from Affymetrix microarray analysis of WT heart tissue, compared to the expression levels of the 129 features correspond-
ing to genes with recovered intragenic ssDNA clones, pooled from WT and KO samples. The x axis is plotted exponentially.
(F) Assignment and percentages of all recovered clones from WT and KO heart tissue.
(G) ssDNA fragments that mapped to endogenous retroelements were plotted to scale against a generic, consensus sequence of L1 (top) and LTR (bottom)
elements. Sense fragments are above each element, and antisense matches are below. For the fragments that mapped to LTRs, only the 50 mapping is shown
to avoid redundancy.two defined ends. PCR amplification yielded two types of prod-
ucts: correctly tailed and copied DNA fragments, and a smaller,
nonspecific amplicon of unincorporated primer from the Klenow
extension step (Figure 5A).592 Cell 134, 587–598, August 22, 2008 ª2008 Elsevier Inc.We used this method to compare the abundance of the DNA
recovered from wild-type and Trex1-deficient hearts, both of
which were on an irf3/ background to eliminate any confound-
ing contribution of inflammation. The DNA recovered from Trex1
KO hearts was more abundant and more complex than DNA
recovered from wild-type hearts based on three criteria. First,
Trex1 KO PCR products amplified five cycles earlier than wild-
type products, suggesting that the KO heart extracts contained
at least 32 times more DNA than the wild-type extracts
(Figure 5B). Second, PCR of the wild-type samples amplified
more of the nonspecific amplicon, whereas all of the Klenow
primer was incorporated into larger products in the KO samples
(Figure 5B). Finally, we found that the wild-type samples had a
significantly higher proportion of clones with an endogenous
(genome-encoded) poly-dT stretch immediately downstream of
the cloned sequence (Figure 5C). These clones were probably
derived from contaminating genomic DNA that was primed with
the poly-dA primer and copied during the Klenow extension step.
After eliminating duplicate clones and clones with endoge-
nous 30 poly-dT sequences from analysis, we categorized the in-
serts of 112 KO and 76 wild-type clones (Figures 5D and 5F; see
also Table S1 available online). We noted several features of
these DNA fragments that collectively provided clues to the ori-
gin and nature of endogenous Trex1 substrates. Interestingly,
over a third of the recovered DNA fragments in both wild-type
and KO samples mapped within genes, a dramatic increase
over the 1% contribution of genic sequence to the mass of
the mouse genome (Figure 5D). Moreover, these DNA fragments
mapped preferentially to genes with abundant expression levels
in heart tissue (Figure 5E). The genic DNA fragments corre-
sponded mostly to intronic sequence, and both sense and anti-
sense DNA fragments were recovered. Further analysis may
reveal quantitative differences in the recovery of these fragments
that may contribute to the32-fold increase in DNA purified from
KO hearts (Figure 5B). At present, however, the significance of
these genic DNA fragments remains unclear, and the frequency
of their recovery was qualitatively similar between wild-type and
KO samples.
Remarkably, DNA fragments derived from endogenous retro-
elements were abundantly represented among the clones de-
rived from KO hearts, but not among wild-type clones (Figures
5D, 5F, and 5G). Of the 25 retroelement sequences recovered
from KO samples, 12 were derived from L1 retrotransposons,
10 were from long terminal repeat (LTR) endogenous retrovi-
ruses, and three were SINE elements (Figure 5F). We did not
observe any complementary clones (clones derived from both
strands of the same DNA fragment). Although we did not se-
quence to saturation in this analysis, this observation suggests
that the recovered DNA fragments were single-stranded. Trex1
is an ssDNA exonuclease, and ssDNA was recently shown to
accumulate in the cytosol of Trex1-deficient cells (Yang et al.,
2007), suggesting that this technique revealed authentic Trex1
DNA substrates.
We mapped the ssDNA fragments to generic, consensus L1
and LTR retroelement sequences, and noted trends that sug-
gested clues about their biogenesis. L1-derived DNA fragments
mapped preferentially to the 30 end of the consensus L1 se-
quence, which may reflect the abundance of defective, 50-
deleted L1 elements in the mouse genome (Figure 5G) (Ostertag
and Kazazian, 2001). We observed an antisense strand bias with
the LTR retrotransposon-derived DNA fragments, but not with
the L1-mapping DNA (Figure 5G).Taken together, these data suggest that ssDNA fragments
derived from endogenous retroelements accumulate within
heart cells of Trex1-deficient mice.
Trex1 Metabolizes DNA of Endogenous Retroelements
To further examine whether endogenous retroelements are rele-
vant substrates of Trex1, we used two genetically marked retro-
elements corresponding to the two major classes of DNA
fragments recovered from Trex1-deficient hearts: a human L1
element (Esnault et al., 2000) and an LTR-containing murine
intracisternal type A particle (IAP; Dewannieux et al., 2004).
The marked elements contain a neomycin resistance cassette
(neor) in reverse orientation to the retroviral coding sequence;
this neor gene is disrupted by a forward-facing intron that pre-
cludes its expression from the plasmid (Figure 6A). Following
transcription of the marked element into mRNA, splicing out of
the intron, reverse transcription, and integration into the host
cell genome, the genomic neor gene becomes active (Dewan-
nieux et al., 2004).
HeLa cells transfected with the wild-type IAP plasmid, but not
a vector witha nonsense mutation in the GAG open reading frame,
formed abundant neomycin-resistant colonies, with each colony
representing a single retrotransposition event (Figure 6B) (Dewan-
nieux et al., 2004). When we cotransfected an expression vector
for Trex1, we observed a dramatic reduction in IAP retrotranspo-
sition efficiency to less than 40%of that incontrol cells (Figure 6B).
Similarly, Trex1 reduced L1 retrotransposition efficiency by over
80% (Figure 6C). In both cases, the blockade was specific for
the retroelement, as ectopic Trex1 expression had no effect on
conventional, plasmid-based neomycin resistance at these con-
centrations (Figure 6D). Consistent with the specificity of Trex1
enzymes for retroviral DNA, but not for plasmid DNA, Trex1 had
no measurable effect on expression of the IAP GAG protein or
protease-dependent processing of GAG (Figure 6E).
We next examined the effect of AGS-causing Trex1 mutations
on IAP and L1 retrotransposition. In the IAP assays, we observed
distinct effects of the different Trex1 mutations on retrotranspo-
sition that correlated with the recessive or dominant nature of
each disease-causing allele. Trex1 R114H and Trex1 V201D,
which cause recessive AGS, had no effect on IAP or L1 retro-
transposition, consistent with the loss of function observed for
these mutants in exonuclease assays (Figure 6F) (Crow et al.,
2006a). In contrast, cotransfection of the D200N catalytic mutant
that causes autosomal-dominant AGS or a similar H195A/D200A
mutant resulted in a substantial increase in IAP retrotransposi-
tion efficiency over that observed in control cells (Figure 6F)
(Rice et al., 2007a). Trex1 functions as a dimer (Mazur and Per-
rino, 2001), suggesting that the increase in IAP retrotransposition
may reflect inhibition of endogenous Trex1 by the catalytic mu-
tants. We did not observe an enhancement of retrotransposition
efficiency by the catalytic mutant forms of Trex1 with the L1 ele-
ment, perhaps reflecting distinct cellular locations of reverse
transcription for LTR and L1 retrotransposons, or different
thresholds for inhibition (Figure 6G). Collectively, these findings
suggest that Trex1 specifically targets reverse-transcribed
endogenous retroviral DNA, revealing a potential connection
between endogenous retroelements, the ISD pathway, and
autoimmune pathology.Cell 134, 587–598, August 22, 2008 ª2008 Elsevier Inc. 593
Figure 6. Trex1 Can Metabolize Endogenous Retroelement DNA
(A) Schematic of the marked IAP element used to measure IAP retrotransposition efficiency. The L1 element was designed with a similar selectable cassette.
(B) HeLa cells were transfected with mutant or WT marked IAP, alone or together with the indicated amounts of Trex1 expression vector.
(C) HeLa cells were transfected with the marked L1 element, alone or with the indicated amounts of Trex1 expression vector.
(D) HeLa cells were transfected with pCDNA3 (which encodes plasmid-based neomycin resistance), alone or with the indicated concentrations of each Trex1
expression vector.
(E) HEK293T cells were transfected with the WT IAP, alone or with the indicated concentrations of HA-tagged Trex1. GAG expression and processing 48 hr
posttransfection was visualized by western blot.
(F) Relative IAP retrotransposition efficiency in the presence of the indicated Trex1 expression vectors. For each Trex1 construct, the left bar is 0 ng, the middle
bar is 250 ng, and the right bar is 500 ng of expression vector. Data are mean ± SEM of triplicate measurements and are representative of five independent
experiments.
(G) Relative L1 retrotransposition efficiency was quantitated in the presence of the indicated mutant forms of Trex1. Data are mean ±SEM, and are representative
of three independent experiments.DISCUSSION
Nucleic acid recognition is an essential innate immune strategy
for detecting viral infection, yet its very nature raises fundamental
questions of self-/non-self discrimination. We describe here
a new mechanism of autoimmunity wherein defective metabo-
lism of intracellular nucleic acids activates a cell-intrinsic autoim-
mune response. Specifically, we identify Trex1 as an ISD-induc-
ible, negative regulator of the ISD response. We genetically
define a pathway linking excessive activation of the ISD
response to autoantibody production and lethal autoimmunity,
thus providing mechanistic insight into the underlying cause of
AGS in humans, with relevance to other diseases associated
with Trex1 mutations. Finally, we identify potential Trex1
substrates by showing that fragments of endogenous retroele-
ment DNA accumulate in the hearts of Trex1-deficient mice,
and that Trex1 can metabolize reverse-transcribed DNA of these
elements.594 Cell 134, 587–598, August 22, 2008 ª2008 Elsevier Inc.Recently, another group reported cell-cycle abnormalities and
chronic activation of DNA-damage checkpoint signaling in
a Trex1-deficient murine cell line and in primary fibroblasts from
a human AGS patient, raising the possibility that these defects
may be linked to the diseases caused by loss of Trex1 (Yang
et al., 2007). We did not detect these abnormalities—slower
growth in culture, chronic activation of p53, and upregulation of
p21—in Trex1-deficient primary murine embryonic fibroblasts
(Figures S1A and S1B). Activation of the ISD pathway occurs in-
dependently of DNA-damage sensors, including ATM, DNA-PK,
p53, and ATR (Stetson and Medzhitov, 2006a), and we did not
find any evidence for DNA damage-inducible gene transcription
in our microarray analysis of Trex1/RAG2 DKO heart tissue
(Figure 3C). Finally, it is unclear how chronic checkpoint signaling
and cell-cycle defects in Trex1-deficient cells would be corrected
by genetic ablation of IRF3, IFNaR1, or RAG2. Together, these
findings indicate that dysregulated activation of the ISD pathway,
rather than chronic checkpoint activation, is the principal cause
of autoimmunity in Trex1-deficient mice. It is possible, however,
that the ISD pathway may be linked to the cell cycle as part of the
antiviral response, perhaps through IFN-dependent induction of
p53 (Takaoka et al., 2003).
More broadly, our findings establish that cytosolic nucleic acid
sensors can initiate autoimmunity if improperly controlled. It
seems that promiscuity is a general property of antiviral nucleic
acid sensors; additional mechanisms that limit access of ligands
to these sensors impose a higher threshold for activation that
cannot be designed into the sensors themselves. Trex1 likely
represents only one example of such threshold-setting mecha-
nisms for cytosolic nucleic acid sensors. Extending this logic,
we propose that analogous pathways might limit the activation
of RIG-I and MDA5 by self-RNA, and that breakdown of these
mechanisms would result in a similar, cell-intrinsic autoimmune
response.
Importantly, the cell-intrinsic mechanism we describe here is
distinct from the two other, well-established mechanisms that
cause autoimmunity. First, defects in central or peripheral
lymphocyte tolerance can lead to the pathological accumulation
of self-reactive lymphocytes that cause disease (Goodnow,
2007); in this case, an innate immune contribution may be unnec-
essary (Gray et al., 2007). Second, activation of non-cell-auton-
omous innate immune recognition through TLRs clearly contrib-
utes to numerous autoimmune syndromes (Marshak-Rothstein
and Rifkin, 2007). Cell-intrinsic initiation of autoimmunity there-
fore defines a third class, with distinct requirements for regula-
tion and unique mechanisms that precipitate lymphocyte-
dependent autoimmunity.
We demonstrate that the ISD pathway is linked to autoanti-
body production in Trex1-deficient mice. Current models of au-
toreactive B cell activation focus on the contribution of TLR
signaling to autoantibody production (Marshak-Rothstein and
Rifkin, 2007). Whether the autoantibody response we document
here is fully independent of TLRs will require further exploration.
One interesting possibility is that cell-intrinsic initiation of autoim-
munity by the ISD pathway in Trex1-deficient mice precedes
a TLR-dependent contribution to autoantibody production. For
example, the ISD ligands that accumulate inside a Trex1-
deficient cell undergoing apoptosis could become TLR9 ligands
after phagocytosis of that cell by a macrophage or dendritic cell,
akin to what was recently shown for viral RNA (Schulz et al.,
2005).
Another key to understanding the pathogenesis of AGS and
related diseases is the nature of the Trex1 substrates that accu-
mulate in its absence. We provide evidence that endogenous
retroviral DNA is a relevant Trex1 substrate. Species- and tis-
sue-specific expression of endogenous retroelements may ex-
plain both the highly stereotyped symptoms of Trex1 deficiency
and the fact that these symptoms are different in humans and
mice. A key question that remains is how Trex1 metabolizes
DNA that is formed by such distinct reverse transcription mech-
anisms: LTR retrotransposons probably undergo reverse tran-
scription in the cytosol, whereas reverse transcription of L1
mRNA is thought to occur in the nucleus (Ostertag and Kazazian,
2001). One possibility is that Trex1 is recruited to reverse-tran-
scribed DNA regardless of its location. Notably, loss of function
mutations in the genes encoding the human RNase H2 enzymealso cause AGS (Crow et al., 2006b), suggesting that RNase
H2 may be involved in metabolism of retroviral RNA-DNA hy-
brids. Others have observed regulated nuclear translocation of
Trex1 (Chowdhury et al., 2006; Yang et al., 2007), although we
did not see this after ISD stimulation (data not shown).
The identification of Trex1 substrates as ISD ligands has inter-
esting implications for the mechanics of the ISD pathway. Typi-
cally, double-stranded DNA is used to experimentally activate
the ISD response. However, Trex1 is an ssDNA exonuclease
(Mazur and Perrino, 2001), and ssDNA oligonucleotides effi-
ciently activate the ISD pathway (data not shown), suggesting
that ISD sensing may involve processing of double-stranded
DNA.
More generally, our results may reconcile a long-standing de-
bate over the proposed contribution of endogenous retroviruses
to autoimmunity (Colmegna and Garry, 2006; Lower, 1999;
Stoye, 1999). This debate focuses on three proposed mecha-
nisms: disruption of an important gene by de novo transposition,
activation of T cells by retroviral antigens, or immunomodulatory
properties of the retroviral proteins themselves. We suggest that
accumulation of reverse-transcribed DNA, rather than any inher-
ent activity of the retroviral proteins, is the key factor that deter-
mines the involvement of endogenous retroviruses in autoimmu-
nity. Importantly, neither the coding specificity of the retroviral
DNA nor its competence for retrotransposition is relevant for
detection by the ISD pathway, suggesting that even defective
retroelements can cause autoimmunity if their reverse-tran-
scribed DNA fails to be properly metabolized. Indeed, of the ret-
roelement-derived ssDNA fragments that we could definitively
map to a single ‘‘parent’’ location, all were derived from defective
retrotransposons (Table S1 and data not shown).
Finally, our findings suggest that the ISD pathway comprises
a hitherto unknown cell-intrinsic retroviral detection system. In
the case of AGS, the ISD pathway may be inappropriately trig-
gered by endogenous retroviral DNA, but it is likely that infec-
tious retroviruses trigger the same response. We found that
treatment of Trex1-deficient mice with the reverse transcriptase
(RT) inhibitor AZT did not rescue from lethality (Figures S2). How-
ever, the mouse genome contains hundreds of diverse RT en-
zymes, only a fraction of which is susceptible to inhibition by
AZT, and it is unclear which of them might be responsible for
generating Trex1 substrates. Detection of reverse-transcribed
DNA may be relevant to other cellular abnormalities, including
genotoxic stress and oncogenic transformation, two conditions
known to activate expression of endogenous retroelements
(Nelson et al., 2003; Rudin and Thompson, 2001). It is intriguing
to note that the ISD pathway (that is, the antiviral response to
natural, phosphodiester DNA) is absent from every transformed
cell line we have examined (data not shown), suggesting that
a functional ISD response may be incompatible with outgrowth
of immortalized cells.
In conclusion, we define Trex1 as a negative regulator of the
ISD response and identify endogenous Trex1 substrates. Just
as commensal bacteria outnumber our own cells by four or five
orders of magnitude, endogenous retroelements outnumber
our genes by at least 100-fold. Both have the potential to be
detected by the immune system and cause autoimmune dis-
ease. Therefore, specific mechanisms evolved to prevent this,Cell 134, 587–598, August 22, 2008 ª2008 Elsevier Inc. 595
and Trex1 represents a mechanism to prevent autoimmunity
caused by endogenous retroelements. The cell-intrinsic initiation
of autoimmunity described here provides a model for integrating
this mechanism into other established models of autoimmunity.
EXPERIMENTAL PROCEDURES
Mice and Reagents
C57Bl/6 mice mice were purchased from Jackson Laboratories (Bar Harbor,
ME). Trex1-deficient mice and immortalized cell lines (Morita et al., 2004)
were generously provided by Dr. Deborah Barnes and Dr. Tomas Lindahl (Can-
cer Research UK). Irf3/ mice (Sato et al., 2000) were kindly provided by
Dr. Tadatsugu Taniguchi (University of Tokyo). RAG2-deficient mice were pur-
chased from Jackson Laboratories, and IFNaR1-deficient mice on a C57Bl/6
background were a gift from Warren Shlomchik (Yale University). The marked
IAP (DJ33-440N1) and L1 elements were generated as previously described
(Dewannieux et al., 2004; Esnault et al., 2000). All murine Trex1 cDNAs were
cloned, mutated, and expressed in pCMV-HA (Clontech) using conventional
techniques. Antisera to Trex1 (BD Biosciences), hemagluttinin epitope (Cell
Signaling Technology), V5 (Invitrogen), calnexin (kindly provided by Dr. Peter
Cresswell, Yale University), and the IAP GAG (generously provided by Drs.
Hal Bogerd and Bryan Cullen, Duke University) were used for western blots
and immunofluorescence.
ISD In Vivo Pulldowns
Approximately 109 bone marrow-derived macrophages were pretreated with
chloroquine (50 mM) to neutralize lysosomal pH, and then transfected with
25 mg per plate of BrdU-substituted, biotinylated 85 base pair ISD complexed
with Lipofectamine 2000 (Invitrogen; ISD sequence available upon request).
After 90 min, the plates were exposed to UV light for 5 min in a Stratalinker
1800 (Stratagene). Cells were lysed in 1% SDS, 50 mM Tris, pH 8.0, 10 mM
EDTA supplemented with Complete protease inhibitors (Roche). Lysates
were diluted in 1% Triton X-100, 150 mM NaCl, 50 mM Tris, pH 8.0, and rotated
overnight with streptavidin-M280 Dynabeads (Dynal Biotech). Washes were
done in the above buffer with either 150 mM or 500 mM NaCl, followed by
a wash in 1% SDS, 1.5 M NaCl. Protein/DNA complexes were boiled off the
beads, separated by gradient SDS-PAGE, and visualized with silver staining
for resolution or Coomassie blue for mass spec preparative gels. Protein
bands were excised and identified at the Stanford PAN facility.
Sucrose Gradients
The 293T cells (2.53 106 per 10 cm dish) were transfected with 2 mg of the in-
dicated expression vectors and harvested 48 hr later into perm buffer (150 mM
NaCl, 50 mM HEPES, and Complete protease inhibitors with 25 mg/ml digito-
nin). Cells were mechanically disrupted by four passages through a 27 gauge
needle, and extracts were cleared three times at 800 3 g. A total of 1.1 ml of
cleared extracts was layered onto 10.8 ml 10%–60% sucrose gradients,
centrifuged in a SW-41 rotor at 40,000 rpm for 2 hr at 4C, and fractionated
before separation by SDS-PAGE and western blotting.
Microarray Analysis
Heart tissue from three pairs of male Trex1/RAG2 DKO mice and RAG2 KO lit-
termates, aged 18, 19, and 28 weeks, was homogenized in RNA-Bee (TelTest)
with a PowerGen 700 (Fisher). RNA preparation was done according to man-
ufacturer’s instructions, and microarray hybridizations to Affymetrix Mouse
Gene Chip 430 2.0 were performed at the W.M. Keck facility at Yale. Features
with >2-fold increased expression in all three pairwise comparisons are pre-
sented in Figure 3C. All microarray data were deposited in the GEO database
(accession no. GSE11698).
Detection of Autoantibodies
Trex1/RAG2 DKO hearts were fixed in 4% paraformaldehyde, cryoprotected
with 30% sucrose in PBS, embedded in OCT medium, and frozen. Sections
(7 mm) were cut on a cryostat, rehydrated, blocked with 5% BSA, 0.1%
Tween-20 in PBS, and incubated overnight at 4C with sera from mice of the
indicated age and genotype, diluted 1:40 in blocking buffer. Bound IgG596 Cell 134, 587–598, August 22, 2008 ª2008 Elsevier Inc.antibodies were detected with Alexa 488-conjugated anti-mouse IgG (Molec-
ular Probes), and sections were counterstained for 5 min with DAPI (10 mg/ml)
before mounting in Vectashield media (Molecular Probes). Hearts were ho-
mogenized with a PowerGen 700 in 1.5 ml buffer (150 mM NaCl, 50 mM
HEPES, 10% glycerol, 1 mM DTT, 2 mM EDTA, Complete protease inhibitors).
Triton X-100 was then added to 1%, and extracts were left on ice for 15 min
with occasional vortexing. Extracts cleared at 16,000 3 g were separated by
SDS-PAGE, transferred to PVDF membranes, and incubated overnight at
4C with 1:500 dilutions of sera. Autoantibodies were detected with horserad-
ish peroxidase-conjugated anti-mouse IgG (Jackson Immunoresearch).
Trex1 Substrate Isolation and Identification
Pooled hearts from Trex1/IRF3 DKO mice or IRF3 KO controls were homoge-
nized in gentle extraction buffer containing 50 mM HEPES, 150 mM NaCl, 10%
glycerol, 200 mM digitonin, 1 mM DTT, 2 mM EDTA, and Complete protease
inhibitors. Cleared extracts were treated with 1 mg/ml proteinase K (Ambion)
for 1 hr at 55C, extracted with phenol:chloroform, treated with RNase A
(50 mg/ml) and RNase T1 (10 U/ml; Ambion) for 1.5 hr at 37C, extracted se-
quentially with phenol:chloroform and then chloroform, and then precipitated,
washed, and resuspended in water. Recovered material was tailed with TdT
(NEB) and 92 mM dTTP/8 mM ddCTP in TdT buffer with 0.75 mM CoCl2 for
25 min at 37C according to a published method (Liu et al., 2003). The tailed
DNA was melted, primed with a poly-dA primer containing a unique 50 se-
quence tag for subsequent amplification, and copied with Klenow polymerase
(NEB) and dNTPs for 90 min at 37C. The copied DNA was then tailed with TdT
and 96 mM dCTP/4 mM ddCTP for 30 min at 37C. PCR amplification of the
tailed DNA was performed with restriction site-containing primers comple-
mentary to the poly-dC tail and to the unique tag upstream of the poly-dA
stretch, and products were directionally cloned into pCDNA3. Clones were
sequenced at the W.M. Keck facility and at Agencourt Biosciences. Insert
sequences were mapped to the mouse genome with BLAST in NCBI and
Ensembl, and retroelement sequences were aligned to consensus elements
using Repbase and RepeatMasker.
Retrotransposition Assays
HeLa cells (53 105) in 60 mm dishes were transfected with 1.5 mg of the neor-
marked retroviral plasmid or pCNDA3, together with the indicated expression
vectors, by using FuGene 6 (Roche). Three days later, cells were harvested,
counted, and plated at a density of 53 105 cells per 10 cm dish. The following
day, cells were put under G418 selection (0.5 mg/ml; Invitrogen). Colonies
were visualized, typically 1 week after selection, by crystal violet staining, as
previously described (Dewannieux et al., 2004).
SUPPLEMENTAL DATA
Supplemental Data include two figures and one table and are available with
this article online at http://www.cell.com/cgi/content/full/134/4/587/DC1/.
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